CD27 and acute myeloid leukemia: have shown that a combination of synthetic NOD2 ligand and IFN- γ produced an inflammatory cytokine profile and activated NK cells in AML blasts which resulted in significantly increased mature CD27- CD11b+ NK cells in a mouse AML model, as well as significantly decreased disease burden and prolonged survival (131).